Xylem Total Liabilities decreased by 2.7% to $5.73B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.0%, from $5.51B to $5.73B. Over 5 years (FY 2020 to FY 2025), Total Liabilities shows relatively stable performance with a 0.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
A rising trend may indicate aggressive expansion or liquidity pressure, while a declining trend suggests deleveraging and improved balance sheet health.
This represents the aggregate sum of all current and non-current financial obligations owed by the company to external p...
Used across all industries to assess the overall debt burden relative to equity and assets.
total_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.74B | $5.05B | $5.05B | $5.01B | $4.99B | $4.88B | $4.45B | $4.35B | $6.19B | $5.96B | $5.94B | $5.72B | $5.42B | $5.45B | $5.61B | $5.51B | $5.88B | $5.85B | $5.89B | $5.73B |
| QoQ Change | — | -12.0% | +0.0% | -0.7% | -0.5% | -2.0% | -8.9% | -2.2% | +42.2% | -3.6% | -0.5% | -3.6% | -5.3% | +0.5% | +3.0% | -1.9% | +6.8% | -0.5% | +0.6% | -2.7% |
| YoY Change | — | — | — | — | -13.1% | -3.3% | -11.9% | -13.2% | +24.1% | +22.1% | +33.4% | +31.5% | -12.4% | -8.7% | -5.5% | -3.8% | +8.6% | +7.4% | +4.9% | +4.0% |